Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Sejal Patel, MSIV Gillian Lieberman, MD Superior Vena Cava Syndrome Sejal Patel, MSIV University of Massachusetts Medical School Beth Israel Deaconess Medical Center Sejal Patel, MSIV Gillian Lieberman, MD Objectives Case Presentation SVC Syndrome Pathogenesis Etiology Clinical Features Menu of Tests Treatment Prognosis Sejal Patel, MSIV Gillian Lieberman, MD Case Presentation 37 year old previously healthy female presenting with cough x 3 weeks, and R neck pain and swelling 10-15 pack year smoking history Physical exam: Mild facial flushing Trace edema in R neck and facial region ? SVC syndrome – Chest CT with contrast ordered Sejal Patel, MSIV Gillian Lieberman, MD Patient’s Chest CT Lung mass BIDMC PACS Sejal Patel, MSIV Gillian Lieberman, MD Patient’s Chest CT SVC Mediastinal mass BIDMC PACS Sejal Patel, MSIV Gillian Lieberman, MD Patient’s Chest CT R Pulmonary artery BIDMC PACS Sejal Patel, MSIV Gillian Lieberman, MD Patient’s Chest CT Collaterals BIDMC PACS Sejal Patel, MSIV Gillian Lieberman, MD Hospital Course Chest CT: RUL spiculated mass compatible with neoplasm Mediastinal lymphadenopathy causing compression of the SVC, R main pulmonary artery and R main stem bronchus Transbronchial biopsy, cervical mediastinoscopy Lymph node biopsy: poorly differentiated carcinoma Dx: Unresectable stage IV non-small cell lung cancer Outpatient chemotherapy (cisplatin and etoposide) and radiation therapy Possible SVC stent for symptomatic relief Sejal Patel, MSIV Gillian Lieberman, MD Superior Vena Cava Syndrome Clinical manifestation resulting from partial or complete obstruction of the superior vena cava Sejal Patel, MSIV Gillian Lieberman, MD Pathogenesis SVC Obstruction Extrinsic compression Benign or malignant process involving R lung, lymph nodes, mediastinal structures Intrinsic or luminal obstruction Neoplastic infiltration, thrombosis Collateral Development Azygous, internal thoracic, lateral thoracic, paraspinous, and esophageal venous systems Sejal Patel, MSIV Gillian Lieberman, MD Collateral Circulation Neckbelow veinsor at the level of the azygous Obstruction vein Æ SVC bypass via superficial venous systems resulting in clinical evidence of SVC obstruction Internal thoracic vein SVC Azygous vein Obstruction above the level of the Hemiazygous azygous vein Æ direct vein SVC bypass and no clinical evidence of SVC obstruction Paraesophageal veins Lateral thoracic vein IVC Netter, Atlas of Human Anatomy Sejal Patel, MSIV Gillian Lieberman, MD Etiology Malignant - 85% Lung cancer (75-80%) Lymphoma (8-10%) Thymoma, mediastinal germ cell tumors, metastases (8-10%) Benign - 10-15% Inflammatory – fibrinosing mediastinitis (histoplasmosis, tuberculosis), sclerosing cholangitis, sarcoidosis, postradiation fibrosis Iatrogenic – thrombosis from CV line, pacemaker electrodes Sejal Patel, MSIV Gillian Lieberman, MD Clinical Features Symptoms Depend on the acuity of SVC obstruction and collateral development Facial, neck, and bilateral upper extremity swelling are the most common presenting symptoms Dyspnea, orthopnea, hoarseness, and cough suggest airway obstruction Head fullness, syncope, and lethargy suggest cerebral edema from venous congestion Clinical signs Facial plethora, tachypnea, venous distension in the neck and chest wall Bending forward or lying down may worsen symptoms Sejal Patel, MSIV Gillian Lieberman, MD SVC Syndrome Distended veins Facial and neck edema www.meddean.luc.edu/.../ phyabn/image15.jpg www.UpToDate.com Sejal Patel, MSIV Gillian Lieberman, MD Differential Diagnosis Pericardial tamponade and heart failure Nephrotic syndrome Mediastinal masses Aortic aneurysm Vasculitis Infections: Tuberculosis, Histoplasmosis, fungal Sejal Patel, MSIV Gillian Lieberman, MD Diagnostic Tests Radiologic Chest X-ray Computerized axial Tomography (CT) Magnetic Resonance Imaging (MRI) Ultrasonography Contrast-enhanced venography Tc 99m scan Histologic Procedures Sputum/pleural fluid cytology Bone marrow biopsy Lymph node biopsy Bronchoscopy Thoracentesis Thoracotomy Special Tests Increased central venous pressure( 20-50 mmHg) Sejal Patel, MSIV Gillian Lieberman, MD Chest X-ray Mediastinal widening Venous collaterals Large azygous vein Dilated L superior intercostal vein (aortic nipple) Mediastinal/hilar masses Pleural effusion Calcifications Mediastinal widening www.embbs.com/aem/photo/sob-xr.jpg Sejal Patel, MSIV Gillian Lieberman, MD Computed Tomography CT image with contrast Mediastinal mass Pulmonary lesion SVC obstruction Hilar adenopathy Pleural effusion SVC obstruction Collaterals www.UpToDate.com Sejal Patel, MSIV Gillian Lieberman, MD Magnetic Resonance Imaging Gradient echo T1-weighted MRI Excellent anatomic visualization Useful if contraindication to IV contrast Paratracheal mass www.UpToDate.com Sejal Patel, MSIV Gillian Lieberman, MD Ultrasonography SVC cannot be directly imaged due to a lack of adequate acoustic window patency can be indirectly determined with normal waveforms in the brachiocephalic and subclavian veins Exclusion of thrombus in the upper extremity, axillary, subclavian, and brachiocephalic veins Sejal Patel, MSIV Gillian Lieberman, MD Ultrasonography Patient with SVC syndrome Patient status post SVC stent Venous pulsatility Respiratory phasicity www.emedicine.com Sejal Patel, MSIV Gillian Lieberman, MD Venography Venogram: Pt with SVC syndrome Most conclusive diagnostic tool Defines SVC obstruction and collateral circulation Identifies thrombus Extrinsic compression of SVC www.emedicine.com Sejal Patel, MSIV Gillian Lieberman, MD Histology Malignancy Small cell lung cancer www.muhealth.org/.../ thoracic/img/cellsmall.jpg Histoplasmosis H. capsulatum www.med.cmu.ac.th/student/ patho/Kamthorn/ Sejal Patel, MSIV Gillian Lieberman, MD Medical management Non-Hodgkins lymphomas, germ cell neoplasms, limited-stage small cell lung carcinoma - responsive to chemotherapy Radiation - 80-90% relieved of SVC syndrome Surgical treatment Thrombolytics for selected cases of acute thrombosis Anticoagulants to prevent clot propagation Diuretics and corticosteroids for laryngeal and cerebral edema Radiation and chemotherapy Treatment Bypass of obstructed SVC Mostly a palliative tool, reserved for patients with advanced intrathoracic disease Endovascular treatment Minimally invasive Thrombolysis, angioplasty, and stent placement 80-90% procedural success rates Sejal Patel, MSIV Gillian Lieberman, MD Endovascular Treatment SVC syndrome L superior intercostal drainage SVC occlusion Stent mounted on a balloon Balloon deployment Status post SVC stent Patent SVC www.emedicine.com Sejal Patel, MSIV Gillian Lieberman, MD Prognosis Benign disease – life expectancy unchanged Malignant obstruction of SVC Untreated: ~30 days life expectancy Treated: < 7 month life expectancy 20% 1-year survival for lung cancer NSCLC - poor prognosis, palliative care + radiation tx 50% 2-year survival for lymphoma Sejal Patel, MSIV Gillian Lieberman, MD Summary SVC syndrome results from extrinsic or intrinsic obstruction of the SVC Clinical presentation depends on the acuity of the obstruction and adequate collateral development Majority of the SVC syndrome cases are caused by a malignant process Variety of radiologic tests are available for diagnosis Important to obtain a histologic diagnosis to guide treatment and determine prognosis Sejal Patel, MSIV Gillian Lieberman, MD Acknowledgements Dr. Phillip Boiselle Dr. Hiroto Hatabu Dr. Paul Spirn Dr. Vandana Dialani The Radiology Residents Dr. Gillian Lieberman Pamela Lepkowski Larry Barbaras Sejal Patel, MSIV Gillian Lieberman, MD References Parish JM, Marschke Rf, Dines DE, Lee RE. Etiologic consideration in Superior vena cava syndrome. Mayo Clin Proc. 1981; 56:407-413. Markman M. Diagnosis and management of superior vena cava syndrome. Cleve Clin J Med 1999; 66:59. Bechtold RE, Wolfman NT, Harstaedt N, Choplin RH. Superior vena cava obstruction: Detection using CT. Radiology 1985; 157:485. Schindler N, Vogelzang RL. Superior vena cava syndrome. Experience with endovascular stents and surgical therapy. Surg Clin North Am 1999; 79:683. Baker GL, Barnes HJ. Superior Vena Cava Syndrome: Etiology, diagnosis and treatment. American Journal of Critical Care. 1992; 1:54-64. Pierson DJ. Disorders of the pleura, mediastinum, and diapragm. In Harrison’s principles of Internal Medicine, 12th Edition. New York: McGraw-Hill; 1991:1115. Drews RE. Superior vena cava syndrome. UpToDate 13.2 2004. Kallab AM. Superior vena cava syndrome. Emedicine 2005. Cumming ML. Superior vena cava syndrome. Emedicine 2003.